Error loading player: No playable sources found
73562
Keynote Session III: Mass Spectrometry Enables More Definitive Process & Product Development Towards Well-Characterized Biotherapeutics: A Personal Account
Date
September 7, 2023
This product is not available for individual purchase, but it is available as part of the following products:
Session Speaker:
Mass Spectrometry Enables More Definitive Process & Product Development Towards Well-Characterized Biotherapeutics: A Personal Account
Jason Rouse, Pfizer, Inc.
Mass Spectrometry Enables More Definitive Process & Product Development Towards Well-Characterized Biotherapeutics: A Personal Account
Jason Rouse, Pfizer, Inc.
Session Chair
Related Products
Technical Seminar: Presented by GenNext Technologies, Inc.
Technical Seminar Lunch & Learn Sessions are for Mass Spec attendees only. HOS attendees and those not wishing to attend should grab their lunch and proceed to the Explore Room (Floor 2)…
Featured Joint Keynote Presentation: Hacking Structural Biology for Drug Delivery Using Protein Footprinting Based Mass Spectrometry
Joint Keynote Presenter Mark R. Chance Has a Message for You [https://www.youtube…
Session VII: Product and Process Characterization
Assay Replacement Strategies using MAM
The Regulator Panel: Can We Talk?
Featured Panelists:
